The Packard Center and ALS United will fund a preclinical study investigating how abnormal TDP-43 protein contributes to ALS.
Tumors were eradicated in 30% of mice receiving cGAS LNPs injected into the tumor, in combination with immune checkpoint blockade.
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...
Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.
A newly discovered protein from Earth's toughest animal is inspiring breakthrough therapies for cancer and cardiovascular ...
It’s no secret that our bodies’ ability to ward off pathogens and mount strong vaccine responses weakens with age, but ...
Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival ...
Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback